Effect of isoflavone-enriched whole soy milk powder supplementation on bone metabolism in ovariectomized mice

키워드

참고문헌 (42)

1. Lecart MP, "Current options for the management of postmenopausal osteoporosis", Expert Opin Pharmacother, 12, pp.2533~2552 (2011)[DOI]
2. Seckin B, "The relationship between breast density and bone mineral density in never users of postme- nopausal hormone therapy", Aging Clin Exp Res, 29, pp.537~541 (2017)[DOI]
3. Rossouw JE, "Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial", JAMA, 288, pp.321~333 (2002)[DOI]
4. Gambacciani M, "Hormone replacement therapy and the prevention of postmenopausal osteoporosis", Prz Menopauzalny, 13, pp.213~220 (2014)
5. Qi S, "Combined effects of phytoestrogen genistein and silicon on ovariectomy-induced bone loss in rat", Biol Trace Elem Res, 177, pp.281~287 (2017)[DOI]
6. Pilsakova L, "The physiological actions of isoflavone phytoestrogens", Physiol Res, 59, pp.651~664 (2010)
7. Vitale DC, "Isoflavones: estrogenic activity, biological effect and bioavailability", Eur J Drug Metab Pharmacokinet, 38, pp.15~25 (2013)[DOI]
8. Moutsatsou P, "The spectrum of phytoestrogens in nature: our knowledge is expanding", Hormones (Athens), 6, pp.173~193 (2007)
9. Cos P, "Phytoestrogens: recent developments", Planta Med, 69, pp.589~599 (2003)[DOI]
10. Huang HY, "One-year soy isoflavone supplementation prevents early postmenopausal bone loss but without a dose-dependent effect", J Nutr Biochem, 17, pp.509~517 (2006)[DOI]
11. Mei J, "High dietary phytoestrogen intake is associated with higher bone mineral density in postmenopausal but not premenopausal women", J Clin Endocrinol Metab, 86, pp.5217~5221 (2001)[DOI]
12. Zhang X, "Prospective cohort study of soy food consumption and risk of bone fracture among postmenopausal women", Arch Intern Med, 165, pp.1890~1895 (2005)[DOI]
13. Min-Sun Kim, "Effects of Soy Isoflavone and", or Estrogen Treatments on Bone Metabolism in Ovariectomized Rats, 2005, pp.8(4), 439~445[DOI]
14. Bitto A, "Effects of genistein aglycone in osteoporotic, ovariectomized rats: a comparison with alendronate, raloxifene and estradiol", Br J Pharmacol, 155, pp.896~905 (2008)[DOI]
15. Nelson HD, "Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis", JAMA, 295, pp.2057~2071 (2006)[DOI]
16. Raisz LG, "Pathogenesis of osteoporosis: concepts, conflicts, and prospects", J Clin Invest, 115, pp.3318~3325 (2005)[DOI]
17. Bergh JJ, "Osteoprotegerin expression and secretion are regulated by calcium influx through the L-type voltage-sensitive calcium channel", Endocrinology, 145, pp.426~436 (2004)[DOI]
18. Klepzig M, "Procollagen type 1 amino-terminal propeptide: a marker for bone metastases in prostate carcinoma", Anticancer Res, 29, pp.671~673 (2009)
19. Ljusberg J, "Proteolytic excision of a repressive loop domain in tartrate-resistant acid phosphatase by cathepsin K in osteoclasts", J Biol Chem, 280, pp.28370~28381 (2005)[DOI]
20. Campbell SE, "Effects of ovarian hormones on exercise metabolism", Curr Opin Clin Nutr Metab Care, 4, pp.515~520 (2001)[DOI]
21. Misso ML, "Differential expression of factors involved in fat metabolism with age and the menopause transition", Maturitas, 51, pp.299~306 (2005)[DOI]
22. Huang S, "Effects of nano calcium carbonate and nano calcium citrate on toxicity in ICR mice and on bone mineral density in an ovariectomized mice model", Nanotechnology, 20, pp.375102~ (2009)[DOI]
23. Zoth N, "Physical activity and estrogen treatment reduce visceral body fat and serum levels of leptin in an additive manner in a diet induced animal model of obesity", J Steroid Biochem Mol Biol, 122, pp.100~105 (2010)[DOI]
24. Zheng W, "Combinatory effects of phytoestrogens and exercise on body fat mass and lipid metabolism in ovariectomized female rats", J Steroid Biochem Mol Biol, 178, pp.73~81 (2018)[DOI]
25. Wu J, "Combined intervention of soy isoflavone and moderate exercise prevents body fat elevation and bone loss in ovariectomized mice", Metabolism, 53, pp.942~948 (2004)[DOI]
26. Hertrampf T, "The bone-protective effect of the phytoestrogen genistein is mediated via ER <TEX>${\alpha}$<", TEX>-dependent mechanisms and strongly enhanced by physical activity, 2007, pp.40, 1529~1535
27. Levis S, "Soy isoflavones in the prevention of menopausal bone loss and menopausal symptoms: a randomized, double-blind trial", Arch Intern Med, 171, pp.1363~1369 (2011)[DOI]
28. Wang H, "Isoflavone content in commercial soybean foods", J Agric Food Chem, 42, pp.1666~1673 (1994)[DOI]
29. Davey RA, "Osteoblast gene expression in rat long bones: effects of ovariectomy and dihydrotestosterone on mRNA levels", Calcif Tissue Int, 67, pp.75~79 (2000)[DOI]
30. Nishizawa Y, "Guidelines for the use of biochemical markers of bone turnover in osteoporosis (2004)", J Bone Miner Metab, 23, pp.97~104 (2005)
31. Taku K, "Effects of soy isoflavone supplements on bone turnover markers in menopausal women: systematic review and meta-analysis of randomized controlled trials", Bone, 47, pp.413~423 (2010)[DOI]
32. Fu SW, "Systematic review and meta-analysis of the bone protective effect of phytoestrogens on osteoporosis in ovariectomized rats", Nutr Res, 34, pp.467~477 (2014)[DOI]
33. Seibel MJ, "Biochemical markers of bone turnover: part I: biochemistry and variability", Clin Biochem Rev, 26, pp.97~122 (2005)
34. Vasikaran SD, "Utility of biochemical markers of bone turnover and bone mineral density in management of osteoporosis", Crit Rev Clin Lab Sci, 45, pp.221~258 (2008)[DOI]
35. Miller PD, "How useful are measures of BMD and bone turnover?", Curr Med Res Opin, 21, pp.545~553 (2005)[DOI]
36. Khosla S, "Minireview: the OPG", RANKL, Endocrinology, pp.2001, 142[DOI]
37. Bateman TA, "Osteoprotegerin and bone loss associated with spaceflight", Drug Discov Today, 7, pp.456~457 (2002)[DOI]
38. Brink E, "Long-term consumption of isoflavone-enriched foods does not affect bone mineral density, bone metabolism, or hormonal status in early postmenopausal women: a randomized, double-blind, placebo controlled study", Am J Clin Nutr, 87, pp.761~770 (2008)[DOI]
39. Lydeking-Olsen E, "Soymilk or progesterone for prevention of bone loss-a 2 year randomized, placebo-controlled trial", Eur J Nutr, 43, pp.246~257 (2004)[DOI]
40. Nikander E, "Effects of phytoestrogens on bone turnover in postmenopausal women with a history of breast cancer", J Clin Endocrinol Metab, 89, pp.1207~1212 (2004)[DOI]
41. Halleen JM, "Tartrate-resistant acid phosphatase 5b: a novel serum marker of bone resorption", J Bone Miner Res, 15, pp.1337~1345 (2000)[DOI]
42. Halleen JM, "Tartrate-resistant acid phosphatase 5B is a specific and sensitive marker of bone resorption", Anticancer Res, 23, pp.1027~1029 (2003)

관련 논문AI추천